Your browser does not support JavaScript or You have disabled it. Most of the features will not work so please enable JavaScript!

Latest posts

Innovations in Medical Aesthetics and Dermatology Updates (Daily Brief Highlights, 21/04/2026)

Innovations in Medical Aesthetics and Dermatology Updates

derm.my Daily Brief Highlights

  1. National Launch of Winlevi for Acne Treatment — The Corner Skin Specialist Centre has been selected as the trial site for Winlevi, the first topical androgen receptor inhibitor designed to treat acne without systemic hormonal side effects.

  2. Emergence of Shingrix as Preferred Shingles Vaccine — Dermatologists are recommending the Shingrix vaccine for adults over 50 and immunocompromised individuals, citing over 90 percent effectiveness in preventing shingles and post-herpetic neuralgia.

  3. ADAMS 2026 and Primary Care Dermatology Conference Open Registration — Registration is now open for the 5th edition of the Aesthetic Dermatology and Medicine Summit 2026 and the inaugural Primary Care Dermatology Conference scheduled for August 2026.

  4. Clinical Focus on Advanced Scar Management — Specialists are highlighting multi-modal approaches for challenging scar cases, including the use of Linerase Collagen and combination therapies to improve skin texture and patient confidence.

  5. MSAM and AMSC Industry Ethics Meeting — The Malaysia Society of Aesthetic Medicine recently held its 3rd AGM to discuss industry growth, focusing on clinical excellence, safety, and ethical patient care for the upcoming year.

  6. Impact of Antibiotics on Skin Health — Medical experts warn that antibiotics can disrupt the gut-skin axis, leading to inflammation, yeast overgrowth, and weakened skin barriers that may cause acne flares or sensitivity.

  7. Advancements in Non-Peeling Chemical Peels — The PRX-T33 treatment is gaining traction as a non-peeling alternative to traditional chemical peels, using a TCA and hydrogen peroxide blend to stimulate deep skin cells while keeping the epidermis intact.

Loading...